Is intensive LDL-cholesterol lowering beneficial and safe?

Lancet. 2010 Nov 13;376(9753):1622-4. doi: 10.1016/S0140-6736(10)61545-0. Epub 2010 Nov 8.

Authors

Bernard M Y Cheung¹, Karen S L Lam

Affiliation

¹ Department of Medicine, Division of Clinical Pharmacology and Therapeutics, University of Hong Kong, Pokfulam, Hong Kong. mycheung@hku.hk

PMID: 21067806
DOI: 10.1016/S0140-6736(10)61545-0

No abstract available

Publication types

Comment

MeSH terms

Anticholesteremic Agents / administration & dosage*
Anticholesteremic Agents / adverse effects
Cardiovascular Diseases / prevention & control*
Cholesterol, LDL / blood*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage*
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
Hypercholesterolemia / drug therapy
Risk Reduction Behavior
Simvastatin / administration & dosage*
Simvastatin / adverse effects

Substances

Anticholesteremic Agents
Cholesterol, LDL
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Simvastatin